23 February 2012
When the Republicans blinked last week in voting to adopt a measure that averts the 27.4% sustainable growth rate reduction in Medicare payments to physicians, which came as part legislation to provide a 2% payroll tax credit to 160 million Americans, President Barack Obama and the Democrats scored a major victory. But the Democratic head of the Senate health panel called it a "devil's deal" – insisting that the plan to take $5 billion away from health reform's prevention fund to pay for the so-called doc fix and the tax credit is a "grave mistake". Plus: Leukaemia drug shortage nears end; Tetraphase wins BARDA contract; and contraception fight continues. - Read more
Duncan Whitney promoted to senior VP at Allegro
Allegro Diagnostics , a molecular diagnostics company developing innovative genomic tests for the ...
Frank Booth made CMO as Sangart expands leadership team
Sangart , a privately-held biopharmaceutical company focused on oxygen-therapeutics agents, has ...
Scott Whitcup joins Questcor board
Biopharmaceutical company Questcor has appointed
Dr Scott Whitcup
to its board of directors. Dr ...
Germany: Orphan drug manufactures beware of the AMNOG
16 November 2011
Get the Flash Player to see this player.
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
